StonvexLoading…
StonvexStonvexStonvexCore line items from ATR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.78B | $3.58B | $3.49B | $3.32B |
Operating Income | $501.04M | $496.50M | $404.02M | $379.27M |
Net Income | $392.79M | $374.54M | $284.49M | $239.29M |
EPS (Diluted) | $5.89 | $5.53 | $4.25 | $3.59 |
Total Assets | $5.25B | $4.43B | $4.45B | $4.20B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $402.42M | $223.84M | $223.64M | $141.73M |
Free Cash Flow OCF − CapEx | $299.58M | $366.93M | $262.90M | $168.19M |
Shares Outstanding | 66.72M | 67.69M | 66.91M | 66.72M |